Back

Does free thyroxine (fT4) predict risk of atherosclerotic cardiovascular disease (ASCVD)?

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Risk Factors and Prevention, Cardiovascular Disease in Special Populations Epidemiology ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Jeffrey Lance Anderson

Intermountain Medical Center, Murray (United States of America)

29 More presentations in this session

Presentation thumbnail
Doctor S. Harb (Cleveland, US)
Abstract Slides
Presentation thumbnail
Doctor V. Aengevaeren (Nijmegen, NL)
Abstract Slides
Presentation thumbnail
Doctor T. Infante (Naples, IT)
Abstract Slides
Presentation thumbnail
Doctor M. Anguita Sanchez (Cordoba, ES)
Abstract Slides
Presentation thumbnail
Doctor G. Brooks (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Risk Factors and Prevention, Cardiovascular Disease in Special Populations

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Session
The best publications on preventive cardiology from the European Heart Journal (EHJ) and the European Journal of Preventive Cardiology (EJPC)
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources